Beam Therapeutics - BEAM - Stock Discussion

This medical research company leverages a modified CRISPR gene-editing technique known as base editing to precisely target and modify genetic mutations that cause chronic disease and congenital disorders.

2 Likes

Anyone following or invested here? Up 77% in the past month

1 Like

me!

but I invested in Jan 21 and Iā€™m still 18% down

damnation

Heh - pretty similar here. -26%. Havent seen any major news recently